Nang Kuang Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 375.75 million compared to TWD 423.1 million a year ago. Net income was TWD 41.02 million compared to TWD 44.79 million a year ago. Basic earnings per share from continuing operations was TWD 0.41 compared to TWD 0.44 a year ago. Diluted earnings per share from continuing operations was TWD 0.41 compared to TWD 0.44 a year ago.